CDSCO Registration for Syringe Pump: Complete Guide for Importers and Manufacturers (2026)

• Syringe pumps are regulated as medical devices under MDR 2017 — classified as Class C or Class D based on clinical use and patient risk, with CDSCO central approval mandatory.
• Importers must file Form MD-14 and obtain an MD-15 import license from CDSCO before clearing any syringe pump shipment at Indian customs.
• Domestic manufacturers of Class C/D syringe pumps must file Form MD-7 and obtain an MD-9 manufacturing licence approved centrally by CDSCO — not the State Licensing Authority.
• Wholesale distributors need a separate MD-41 application and MD-42 wholesale license from the State Licensing Authority before supplying syringe pumps in India.

Introduction

CDSCO registration for syringe pumps is mandatory under India's Medical Devices Rules (MDR), 2017. Syringe pumps are classified as Class C or Class D medical devices depending on their intended clinical use. Importers file Form MD-14 and receive an MD-15 import license from CDSCO. Manufacturers of Class C/D syringe pumps file Form MD-7 and receive an MD-9 license. Wholesale distributors apply via MD-41 and receive an MD-42 license from the State Licensing Authority. All central license applications are filed through the CDSCO Sugam portal.

What Is a Syringe Pump and Why Does CDSCO Regulate It?

A syringe pump is a precision medical device that delivers controlled volumes of fluid, medication, or nutrition directly into a patient's bloodstream or body cavity at a programmed flow rate. By driving the plunger of a syringe at a controlled speed, these devices ensure that highly potent drugs — including anaesthetics, vasopressors, chemotherapy agents, insulin, and anticoagulants — are administered accurately over time.

Because errors in infusion rate or volume can cause serious patient harm, including drug overdose, underdose, or air embolism, syringe pumps are classified as high-risk medical devices in India. The Central Drugs Standard Control Organization (CDSCO), operating under the Drugs and Cosmetics Act, 1940 and the Medical Devices Rules, 2017 (MDR 2017), brings all syringe pumps under mandatory registration and licensing before they can be legally imported, manufactured, or sold in the Indian market.

CDSCO registration for syringe pumps ensures that every device used in Indian hospitals, ICUs, operation theatres, and home care settings meets verified safety, performance, and quality standards.

Medical Device Classification Under MDR 2017: Class A, B, C, and D

MDR 2017 classifies all medical devices into four risk-based classes. The classification drives the entire regulatory pathway — which authority approves the license, what documents are required, and how long the process takes.

Class	Risk Level	Regulatory Authority	Licence Forms
Class A	Low risk	State Licensing Authority (SLA)	MD-3 (mfg) / MD-5 (licence)
Class B	Low-moderate risk	State Licensing Authority (SLA)	MD-3 (mfg) / MD-5 (licence)
Class C	Moderate-high risk	CDSCO (Central)	MD-7 (mfg) / MD-9 (licence); MD-14/MD-15 (import)
Class D	High risk	CDSCO (Central)	MD-7 (mfg) / MD-9 (licence); MD-14/MD-15 (import)

Note: The vast majority of syringe pumps — including standard infusion syringe pumps, ICU syringe drivers, PCA pumps, and chemotherapy pumps — are classified as Class C or Class D. This means their licenses are approved centrally by CDSCO, not by the State Licensing Authority.

Syringe Pump Classification Under CDSCO MDR 2017: Class A, B, C, and D

CDSCO classifies syringe pumps and related infusion devices under the Medical Devices Rules, 2017 Third Schedule. Classification is determined by intended clinical use, degree of patient contact, whether the device is active or passive, and the potential risk to the patient if the device fails or malfunctions.

Class A Syringe Pump Related Devices — Low Risk

Class A covers basic, non-powered, non-invasive accessories with minimal patient risk. Standalone syringe pumps are not Class A, but certain ancillary accessories and non-powered consumables used alongside syringe pump systems may fall here.

CLASS A — Low Risk Syringe Pump Accessories
Device / Accessory	Typical Use	Patient Contact	Regulated By
Syringe pump pole clamps / mounting brackets	Securing pump to IV pole or rail	None — indirect	State Licensing Authority
Non-sterile syringe pump carry bags / cases	Transport and storage of pump	None	State Licensing Authority
Manual syringe barrel holders (non-motorised)	Manual fluid administration aid	Indirect	State Licensing Authority
Basic reusable syringe holders (no drive mechanism)	Positioning syringes for gravity flow	Indirect	State Licensing Authority

Class B Syringe Pump Related Devices — Low to Moderate Risk

Class B includes devices with slightly elevated risk profiles — typically non-powered gravity infusion accessories, basic manual infusion aids, and simple fluid delivery components that do not directly drive or programme drug delivery rates.

CLASS B — Low to Moderate Risk Syringe and Infusion Accessories
Device / Accessory	Typical Use	Patient Contact	Regulated By
Gravity infusion sets (non-electronic)	Basic IV fluid administration by gravity	Indirect — vascular	State Licensing Authority
Burette infusion sets	Measured-volume gravity infusion, paediatric use	Indirect — vascular	State Licensing Authority
Sterile infusion tubing sets (non-pump specific)	IV fluid delivery without electronic pump	Indirect — vascular	State Licensing Authority
Non-return valves / anti-reflux valves for infusion lines	Preventing backflow in IV lines	Indirect — vascular	State Licensing Authority
Needleless connectors for infusion systems	Safe IV access without needle	Indirect — vascular	State Licensing Authority
Luer lock / luer slip syringes (standard medical grade)	Fluid withdrawal and manual injection	Short-term patient contact	State Licensing Authority

Class C Syringe Pumps — Moderate to High Risk

Class C is the primary classification for the vast majority of syringe pumps used in Indian hospitals and clinical settings. These are active, motorised, programmable devices that directly control the rate and volume of medication delivery into patients. Any malfunction — such as a free-flow error, incorrect rate delivery, or occlusion failure to alarm — can cause serious patient harm. CDSCO approves all import and manufacturing licences for Class C syringe pumps centrally.

CLASS C — Moderate to High Risk Syringe Pumps (CDSCO Regulated)
Syringe Pump Type	Clinical Application	Key Feature	Regulated By
Standard Hospital Syringe Pump	ICU, ward-based continuous drug infusion	Programmable rate and volume, occlusion alarm	CDSCO (Central)
Dual-Channel Syringe Pump	Simultaneous delivery of two drugs	Two independent drive channels in one unit	CDSCO (Central)
Multi-Channel Syringe Pump	Multiple concurrent drug infusions	3–8 independent channels, modular design	CDSCO (Central)
Neonatal / Paediatric Syringe Pump	Drug delivery in neonates and children	Ultra-low flow rates (0.1 ml/hr or less), small-volume precision	CDSCO (Central)
Anaesthesia Syringe Pump / TCI Pump	Anaesthetic drug infusion in OT	Target Controlled Infusion (TCI) algorithms	CDSCO (Central)
Patient-Controlled Analgesia (PCA) Pump	Post-operative self-administered pain relief	Patient demand bolus + continuous basal rate	CDSCO (Central)
Ambulatory Syringe Pump	Outpatient / home care infusion therapy	Lightweight, portable, battery-operated	CDSCO (Central)
Enteral Feeding Syringe Pump	Tube feeding — nasogastric / PEG route	Designed for enteral nutrition delivery	CDSCO (Central)
Epidural Infusion Pump (syringe-based)	Epidural anaesthesia and pain management	High-pressure occlusion detection, low flow	CDSCO (Central)
Insulin Infusion Pump (external, hospital-grade)	Continuous insulin therapy — ICU / DKA	Precision micro-delivery of insulin solutions	CDSCO (Central)
Chemotherapy Syringe Pump	Cytotoxic drug infusion in oncology	Chemical-resistant components, closed system compatibility	CDSCO (Central)
Anti-thrombolytic / Heparin Infusion Syringe Pump	Continuous anticoagulant therapy	Precise low-volume delivery with dose error reduction	CDSCO (Central)
Veterinary Syringe Pump	Drug infusion in animals	Adapted flow ranges for veterinary clinical use	CDSCO (Central)
Smart Syringe Pump with Drug Library	ICU / critical care with dose safety features	Integrated drug library, soft and hard dose limits	CDSCO (Central)
Wireless / Network-Connected Syringe Pump	Hospital-wide infusion management	LAN/Wi-Fi connectivity, EMR/EHR integration	CDSCO (Central)

Class D Syringe Pumps — High Risk

Class D syringe pumps are the highest-risk category — devices used in life-critical situations where device failure directly endangers patient life. These include implantable drug delivery systems and pumps used in intensive cardiac, neurological, or neonatal life support contexts where a dosing error or mechanical failure could be immediately fatal.

CLASS D — High Risk Syringe Pumps (CDSCO Regulated)
Syringe Pump Type	Clinical Application	Key Feature	Regulated By
Implantable Drug Delivery Pump (syringe-based mechanism)	Long-term intrathecal / intraspinal drug delivery	Surgically implanted, refillable reservoir	CDSCO (Central)
Intrathecal Baclofen Infusion Pump	Spasticity management via spinal drug delivery	Programmable implanted pump, continuous spinal infusion	CDSCO (Central)
Neonatal Life-Critical Infusion Syringe Pump	Drug delivery in critically ill neonates on life support	Sub-0.1 ml/hr precision, integration with ventilator / monitor alarms	CDSCO (Central)
Intra-Aortic Balloon Pump (IABP) Drive System	Cardiac assist during cardiogenic shock	Synchronised counterpulsation — directly life-supporting	CDSCO (Central)
High-Pressure Contrast Media Injector (syringe-based)	Intravascular contrast injection during angiography / CT	High-pressure delivery into vascular system	CDSCO (Central)
Closed-Loop Insulin Delivery System (Artificial Pancreas component)	Automated insulin delivery integrated with CGM	Algorithm-controlled, closed-loop feedback — life-critical	CDSCO (Central)

CDSCO License Forms for Syringe Pumps: Quick Reference

Activity	Application Form	Licence / Grant Form	Issued By	Device Class
Import of syringe pumps	MD-14	MD-15	CDSCO (Central)	All classes (A–D)
Wholesale distribution	MD-41	MD-42	State Licensing Authority	All classes (A–D)
Manufacturing — Class A / B	MD-3	MD-5	State Licensing Authority	Class A & B
Manufacturing — Class C / D	MD-7	MD-9	CDSCO (Central)	Class C & D

Note: Since nearly all clinical syringe pumps are Class C or Class D, both import (MD-14/MD-15) and manufacturing (MD-7/MD-9) licenses are approved by CDSCO centrally. The State Licensing Authority is relevant only for Class A/B accessories and for wholesale (MD-41/MD-42) licenses across all classes.

MD-14 Application: Import License for Syringe Pumps in India

Any Indian entity that imports syringe pumps from an overseas manufacturer for commercial sale, distribution, demonstration, or clinical use in India must hold a valid CDSCO import license in Form MD-15, obtained by filing a Form MD-14 application.

Who Must File Form MD-14?

• Indian importers and distributors importing finished syringe pumps from overseas OEMs
• Indian subsidiaries of foreign medical device manufacturers
• Authorized Indian Representatives (AIR) acting on behalf of foreign principals
• Entities importing syringe pump accessories classified as notified medical devices

MD-14 Step-by-Step Application Process

• Register on the CDSCO Sugam portal as an importer entity
• Appoint an Authorized Indian Representative (AIR) if the overseas manufacturer has no Indian subsidiary
• Classify the syringe pump under MDR 2017 Third Schedule — confirm Class C or D
• Ensure the device holds a valid international regulatory approval — CE Mark, US FDA 510(k) or PMA, TGA, or equivalent
• Compile the complete Technical File / Summary Technical Documentation (STED)
• Prepare Essential Principles Checklist (EPC) per Schedule III of MDR 2017
• Pay the prescribed government fee via the Sugam portal
• File Form MD-14 online — attach all documents in prescribed format
• CDSCO scrutinizes the application and may raise technical, clinical, or document queries
• Respond to all Additional Information (AI) requests within stipulated timelines
• CDSCO grants the import license in Form MD-15 upon satisfactory review

Documents Required for MD-14 (Import License — Syringe Pump)

Document	Details / Requirement
Form MD-14 (duly filled)	Online submission via CDSCO Sugam portal
Certificate of incorporation / business registration	Of the Indian importer entity
Authorisation letter from overseas manufacturer	Appointing the Indian entity as AIR or importer
International regulatory approval certificate	CE Mark (EU MDR / MDD), US FDA 510(k) / PMA, TGA, Health Canada etc.
ISO 13485 certificate of the manufacturer	Valid quality management system certification
Device description and intended use statement	Detailed clinical indication and mode of action
Risk classification justification	Per MDR 2017 Third Schedule classification rules
Essential Principles Checklist (EPC)	Schedule III MDR 2017 — compliance mapping to safety & performance
Summary Technical Documentation (STED) / Technical File	Full safety, performance, and biocompatibility evidence package
IEC 60601-1 test report	General electrical safety — from NABL / accredited laboratory
IEC 60601-2-24 test report	Safety of infusion pumps and controllers — specific standard
IEC 60601-1-6 (usability / human factors) data	Usability engineering file for syringe pump interface
IEC 62133 / battery safety report (if applicable)	For portable / ambulatory syringe pumps
Software documentation — IEC 62304	Software lifecycle file for embedded pump software
Risk management file (ISO 14971)	Risk analysis, evaluation, and residual risk acceptance
Clinical evaluation report	Per CDSCO / MEDDEV guidelines — literature or clinical data
Biocompatibility data (ISO 10993)	For fluid-path and patient-contact components
Post-market surveillance plan	Adverse event reporting and vigilance strategy
Labelling (draft) and Instructions for Use (IFU)	In English; bilingual where required
Unique Device Identification (UDI) details	Per CDSCO UDI framework
Import Export Code (IEC) of importer	Issued by DGFT, India
Declaration of conformity	Signed by authorised signatory of manufacturer

Government Fee for MD-14 (Syringe Pump Import License)

Fee Category	Amount
Application fee — Class C syringe pump	As per MDR 2017 Second Schedule (refer Sugam portal for current amount)
Application fee — Class D syringe pump	As per MDR 2017 Second Schedule (refer Sugam portal for current amount)
Import licence renewal fee	Per Second Schedule of MDR 2017

Note: Fee amounts under MDR 2017 are periodically revised by CDSCO. Always verify the current fee applicable to your device class on the CDSCO Sugam portal before payment. Filing with incorrect fee leads to application rejection.

MD-15: Grant of Import License for Syringe Pumps

On satisfactory review of the MD-14 application and all submitted technical documents, CDSCO issues the import license in Form MD-15. This is the legal authorisation to import the specified syringe pump model(s) into India for commercial sale or distribution.

Key Features of the MD-15 Import License

• Model-specific — covers the exact syringe pump model(s) and variants listed in the application
• Importer-specific — issued in the name of the Indian entity or AIR
• Records the overseas manufacturer's name, manufacturing site address, and country of origin
• Valid for 3 years for Class C and D devices — must be renewed before expiry
• Required at Indian customs for each import shipment — must be produced on demand
• Any change in device model, manufacturer site, labelling, or formulation requires an amendment application

MD-15 Licence Parameter	Details
Form	MD-15
Issued by	CDSCO (Central Drugs Standard Control Organisation)
Covers	Specified syringe pump model(s) from specified overseas manufacturer
Validity	3 years (Class C and D devices)
Renewal	File renewal on Sugam portal before expiry
Amendment	Mandatory for any device, site, or labelling change
Customs requirement	Copy of MD-15 required for each import consignment clearance

MD-41 Application: Wholesale License for Syringe Pumps

A company that distributes, supplies, or sells syringe pumps to hospitals, nursing homes, diagnostic centres, or other end-users within India must hold a valid wholesale license in Form MD-42 from the State Licensing Authority of the state in which it operates.

It is important to understand that the import license (MD-15) gives you the right to bring syringe pumps into India. The wholesale license (MD-42) gives you the right to distribute and sell those devices within India. Both are required if you are both the importer and the distributor.

Who Needs an MD-41 Wholesale License?

• Medical device distributors supplying syringe pumps to hospitals and healthcare facilities
• Importers who also act as distributors of their own imported syringe pump portfolio
• State-level stockists and regional depots of national medical device companies
• Branches of companies operating in multiple states — each state requires a separate MD-42

MD-41 Application Process

• Identify the State Licensing Authority (SLA) of the relevant state
• Arrange appropriate premises with adequate storage space and conditions for medical devices
• Appoint a technically qualified person as required under MDR 2017 and state notifications
• Prepare all required documents — list below
• File Form MD-41 with the SLA — online via state portal or physical submission depending on state
• SLA may conduct a premises inspection before granting the license
• Pay the prescribed state government fee
• SLA issues the wholesale license in Form MD-42 upon satisfactory compliance

Documents Required for MD-41 (Wholesale License — Syringe Pump)

Document	Details
Form MD-41 (duly filled)	Submitted to the State Licensing Authority
Proof of business premises	Ownership certificate or rental / lease agreement
Layout plan of storage and office area	Showing dimensions, storage racks, and conditions
Business entity registration	GST certificate, company incorporation, partnership deed etc.
Copy of valid MD-15 import licence (if importer-distributor)	Showing authorisation for the products being distributed
Details of technically qualified person	Qualification documents as per MDR 2017 / SLA requirement
Declaration of compliance	Signed by the business owner / authorised signatory
NOC or trade licence from local authority (state-specific)	As required by the state SLA

MD-42: Grant of Wholesale License for Syringe Pumps

The State Licensing Authority issues the wholesale medical device license in Form MD-42 after verifying the MD-41 application and, where applicable, inspecting the premises. This licence is mandatory before the first syringe pump is supplied to any customer in that state.

MD-42 Licence Parameter	Details
Form	MD-42
Issued by	State Licensing Authority (SLA)
Covers	Wholesale distribution of medical devices (specified categories) in the state
Validity	Typically 5 years — confirm with relevant SLA
Renewal	Apply before expiry; updated documents required
Multi-state operations	Separate MD-42 required for each state of distribution
Display requirement	Licence must be displayed at the principal place of business

MD-3 Application and MD-5 License: Manufacturing for Class A and B Syringe Pump Accessories

Indian manufacturers producing Class A or Class B syringe pump-related accessories — such as non-powered infusion sets, gravity drip accessories, or basic consumables — apply for a manufacturing licence through Form MD-3 filed with the State Licensing Authority (SLA) of their manufacturing state.

MD-3 Application Process (Class A / B)

• Identify the State Licensing Authority for the state where manufacturing takes place
• Ensure the manufacturing facility complies with Schedule I of MDR 2017 (GMP requirements)
• Build a quality management system aligned to ISO 13485 or equivalent
• Appoint technically qualified personnel as prescribed under MDR 2017 Schedule II
• Prepare all required documents — technical file, device list, premises details
• File Form MD-3 with the SLA along with all supporting documents and prescribed fee
• SLA conducts a GMP inspection of the manufacturing facility
• Address inspection observations within the timelines given by the SLA
• SLA grants the manufacturing license in Form MD-5 upon satisfactory compliance

Documents Required for MD-3 (Class A / B Manufacturing License)

Document	Details
Form MD-3 (duly filled)	Submitted to State Licensing Authority
Proof of manufacturing premises	Ownership or lease agreement
Site master file and factory layout	Showing manufacturing, QC, and storage areas
List of devices to be manufactured	With description, intended use, and device class
Quality management system documentation	ISO 13485 aligned or equivalent QMS
Equipment list with qualification records	All production and testing equipment
Qualification and experience of technical staff	As per MDR 2017 Schedule II
Process validation and test protocols	Per device being manufactured
Risk management file (ISO 14971)	Risk analysis documentation
Draft labelling and IFU	For each product intended for manufacture

MD-5 Licence Parameter	Details
Form	MD-5
Issued by	State Licensing Authority (SLA)
Applicable to	Class A and Class B medical device manufacturers
Validity	Typically 5 years — as per MDR 2017 and state notifications
Renewal	Before expiry; re-inspection may be required by SLA
Scope	Facility-specific and product category-specific

MD-7 Application and MD-9 License: Manufacturing License for Class C and D Syringe Pumps

This is the most rigorous regulatory pathway for Indian manufacturers of clinical syringe pumps. Since standard hospital syringe pumps, ICU infusion pumps, PCA pumps, and high-risk Class D devices are all regulated centrally, their manufacturing licenses are applied for via Form MD-7 and granted by CDSCO — not the State Licensing Authority.

MD-7 Application Process (Class C / D Syringe Pump Manufacturing)

• Register on the CDSCO Sugam portal as a medical device manufacturer
• Establish a manufacturing facility fully compliant with Schedule I of MDR 2017
• Obtain ISO 13485 certification from an NABCB-accredited or internationally recognized certification body
• Complete device design and development — design history file, verification, and validation
• Conduct full technical testing per IEC 60601-1 and IEC 60601-2-24 at an accredited laboratory
• Develop the complete Essential Principles Checklist (EPC) per Schedule III of MDR 2017
• Prepare clinical evaluation report — literature-based or clinical study as required
• Build the full Risk Management File per ISO 14971
• Prepare IEC 62304 software lifecycle documentation for all embedded software
• File Form MD-7 on the Sugam portal with all required documents and prescribed fee
• CDSCO scrutinises the technical file and may raise technical, clinical, or quality queries
• CDSCO conducts a GMP audit of the manufacturing facility
• Respond to all CDSCO queries and address GMP audit observations within given timelines
• CDSCO grants the manufacturing license in Form MD-9 upon satisfactory review and audit

Documents Required for MD-7 (Class C / D Syringe Pump Manufacturing License)

Document	Details / Notes
Form MD-7 (duly filled)	Online submission via CDSCO Sugam portal
Certificate of incorporation	Company / entity registration documents
ISO 13485 certificate	From NABCB-accredited or equivalent certification body
Manufacturing facility details and site layout	Detailed GMP-compliant factory documentation
Device description and intended use	For each syringe pump model
Risk classification justification	Per MDR 2017 Third Schedule
Essential Principles Checklist (EPC)	Schedule III MDR 2017 — full compliance mapping
Risk management file (ISO 14971)	Device risk analysis, evaluation, and control
Design history file / technical documentation	Engineering drawings, design V&V, DHF
IEC 60601-1 test report	General electrical safety — NABL / accredited lab
IEC 60601-2-24 test report	Safety of infusion pumps and controllers — essential for syringe pumps
IEC 60601-1-6 usability / human factors engineering file	User interface safety for syringe pump programming
IEC 60601-1-8 alarm system documentation	Alarm systems on infusion / syringe pumps
IEC 62304 software lifecycle documentation	For all embedded firmware and software
IEC 62133 battery safety (if applicable)	For portable / ambulatory syringe pump models
Biocompatibility data (ISO 10993)	For all fluid-path and patient-contact materials
Clinical evaluation report	Per CDSCO/MEDDEV guidelines — clinical data or literature
Process validation records	Sterilisation (if applicable), manufacturing process validation
Post-market surveillance plan	Vigilance, complaint handling, PMCF, PSUR strategy
Sterility data (if applicable)	For sterile consumables manufactured alongside the pump
Draft labelling and IFU	In English; per MDR 2017 labelling requirements
Unique Device Identification (UDI) details	Per CDSCO UDI framework
Declaration of conformity	Signed by authorised signatory

MD-9 Licence Parameter	Details
Form	MD-9
Issued by	CDSCO (Central Drugs Standard Control Organisation)
Applicable to	Class C and Class D medical device manufacturers
Validity	3 years (as per MDR 2017)
Renewal	Before expiry; GMP re-audit may be conducted by CDSCO
Scope	Facility-specific, device category-specific, and model-specific
Post-grant obligation	Adverse event reporting, PMCF, vigilance, annual PSUR

All Four License Pathways Compared: Side-by-Side

Criteria	MD-14/MD-15 (Import)	MD-3/MD-5 (Mfg A/B)	MD-7/MD-9 (Mfg C/D)	MD-41/MD-42 (Wholesale)
Who it is for	Syringe pump importers	Mfrs of Class A/B accessories	Mfrs of Class C/D syringe pumps	Wholesale distributors
Filed with	CDSCO (Central)	State Licensing Authority	CDSCO (Central)	State Licensing Authority
Device class	All (A–D)	Class A and B only	Class C and D	All (A–D)
GMP inspection	Document scrutiny	SLA site inspection	CDSCO GMP audit	Premises inspection
ISO 13485 required	Overseas mfr must hold it	Yes (or equivalent QMS)	Yes — mandatory	Not typically required
Clinical data needed	Yes (Class C/D)	Minimal (Class A/B)	Yes — mandatory	No
Key technical standard	IEC 60601-2-24	IEC 60601-1 (basic)	IEC 60601-2-24 (mandatory)	Not applicable
Typical timeline	6–18 months (Class C/D)	3–9 months	12–24 months	4–12 weeks
Licence validity	3 years (Class C/D)	5 years (typical)	3 years	5 years (typical)

Key Standards for CDSCO Registration of Syringe Pumps

CDSCO expects importers and manufacturers to demonstrate compliance with internationally recognised technical standards applicable to syringe pumps. Here are the primary standards:

Standard	Scope	Relevance to Syringe Pumps
IEC 60601-1:2005+A1:2012	General electrical safety and performance — medical electrical equipment	Mandatory for all powered syringe pumps
IEC 60601-2-24:2012	Particular requirements for safety of infusion pumps and controllers	The primary standard for syringe pumps — covers flow accuracy, occlusion, free-flow protection
IEC 60601-1-6:2010+A1:2013	Usability engineering — human factors	Covers syringe pump user interface, programming safety, alarm acknowledgement
IEC 60601-1-8:2006+A1:2012	Alarm systems for medical electrical equipment	Syringe pump alarm system design and performance
IEC 62304:2006+A1:2015	Medical device software — software lifecycle processes	All syringe pumps with embedded firmware or drug library software
ISO 14971:2019	Risk management for medical devices	Risk analysis for pump failure modes — free-flow, occlusion, air-in-line
ISO 13485:2016	Quality management systems for medical devices	Mandatory for all manufacturers applying for MD-7/MD-9
ISO 10993 (series)	Biocompatibility evaluation of medical devices	Fluid-path components in contact with infused fluids
IEC 62133	Secondary lithium cell and battery safety	Portable and ambulatory syringe pumps with rechargeable batteries

Processing Timelines: How Long Does CDSCO Registration Take for Syringe Pumps?

Licence Type	Typical Timeline	Key Factors
MD-15 Import Licence (Class C syringe pump)	6 to 18 months	Document completeness, CDSCO query rounds, technical data quality
MD-15 Import Licence (Class D syringe pump)	9 to 24 months	Higher clinical scrutiny, additional queries for life-critical devices
MD-9 Manufacturing Licence (Class C/D)	12 to 24 months	GMP audit scheduling, design file depth, query response speed
MD-5 Manufacturing Licence (Class A/B accessories)	3 to 9 months	SLA workload, GMP inspection scheduling
MD-42 Wholesale Licence	4 to 12 weeks	State SLA workload, premises compliance, document completeness

Note: Applications with complete documents, a well-prepared technical file, and IEC 60601-2-24 test reports from accredited laboratories consistently process faster than incomplete submissions. Every query round from CDSCO can add 4 to 8 weeks to the timeline.

Post-Market Compliance Obligations for Syringe Pump License Holders

Receiving an MD-15 or MD-9 license is not the end of your regulatory obligations. Both importers and manufacturers must maintain active post-market compliance under MDR 2017.

• Adverse Event Reporting: Serious incidents, near-misses, and malfunctions must be reported to CDSCO within prescribed timelines — typically 10 days for life-threatening events
• Field Safety Corrective Actions (FSCA): Initiate, report, and close out any product recalls or field safety notices in India
• Post-Market Clinical Follow-Up (PMCF): Continue collecting real-world clinical data to support safety evidence
• Periodic Safety Update Reports (PSUR): Submit as required by CDSCO for higher-risk devices
• Complaint Handling: Maintain a documented process for receiving, investigating, and closing customer complaints
• Labelling Changes: Any modification to labelling or IFU requires CDSCO approval before implementation
• License Renewal: File MD-15 and MD-9 renewals before the 3-year expiry — operating with an expired license is a violation
• UDI Compliance: Implement Unique Device Identification as CDSCO's UDI mandate rolls out across device classes

2026 Regulatory Updates: What Syringe Pump Importers and Manufacturers Need to Know

Strengthened Port-Level Enforcement

CDSCO has significantly increased enforcement at Indian ports of entry for notified medical devices. Syringe pumps arriving without a valid MD-15 import licence are being detained, and repeat violations are drawing heavier penalties. If you have been importing syringe pumps without a licence, getting compliant is now more urgent than it has ever been.

IEC 60601-2-24 Compliance Now Closely Scrutinized

CDSCO technical officers are increasingly scrutinising IEC 60601-2-24 test reports for flow accuracy, occlusion alarm sensitivity, and free-flow protection data. Submissions relying on older test reports or reports from non-accredited laboratories are facing queries. Ensure your test reports are current and from NABL-accredited or internationally accredited laboratories.

Smart Pumps and Drug Library Devices — Additional Regulatory Attention

Syringe pumps with integrated drug libraries, dose error reduction systems (DERS), Wi-Fi connectivity, and EHR/EMR integration are receiving additional scrutiny at CDSCO. Software validation per IEC 62304, cybersecurity risk documentation, and human factors data per IEC 60601-1-6 are increasingly being requested during query rounds for smart pump registrations.

UDI Implementation Timeline

CDSCO's Unique Device Identification (UDI) rollout is progressing through device categories. Importers and manufacturers of syringe pumps should prepare UDI labelling and database submission plans now, as phased UDI mandates for higher-risk devices are expected to include Class C and D infusion devices.

Mandatory CDSCO Sugam Portal for All Class C/D Applications

As of 2026, all MD-14 and MD-7 applications for Class C and D devices — including syringe pumps — must be submitted entirely through the CDSCO Sugam portal. Hybrid or partial paper submissions are not accepted. Ensure your organisation has an active Sugam account, digital signature certificates, and familiarity with the portal's document upload requirements.

Benefits of Working with a CDSCO Syringe Pump Registration Consultant

Challenge	How a Consultant Adds Value
Correct device classification	Determines Class C vs D — avoids under-classification which can trigger enforcement action
Technical file / STED preparation	Structures the complete documentation package to meet CDSCO's specific expectations
Standard compliance mapping	Maps IEC 60601-2-24, ISO 14971, IEC 62304 test data to the EPC
Sugam portal filing	Handles all digital submissions, fee payment, and document formatting requirements
Query response management	Writes technically precise, well-evidenced responses to CDSCO deficiency letters
GMP audit preparation	For manufacturers: prepares the facility and documentation for CDSCO GMP audit
Drug library / software regulatory strategy	Advises on IEC 62304, cybersecurity, and human factors documentation for smart pumps
Multi-state wholesale licensing	Manages MD-41 filings across multiple states for pan-India distribution
Post-market compliance setup	Builds adverse event reporting, PMCF, and vigilance systems
Renewal management	Proactively tracks MD-15 and MD-9 expiry to prevent licence lapse

If you are importing syringe pumps into India or manufacturing them domestically, Silvereye Certifications handles the full CDSCO registration process — from initial device classification and technical file preparation to license grant and ongoing post-market compliance. Their team has hands-on experience with the Sugam portal workflow and the documentation standards CDSCO expects for Class C and D infusion devices.

Conclusion

CDSCO registration for syringe pumps in India is a well-defined but technically demanding regulatory process. The pathway you follow depends on whether you are importing or manufacturing, and whether your syringe pump is Class C or Class D — which most clinical infusion pumps are.

For importers, the journey is Form MD-14 to Form MD-15 — with CDSCO expecting a complete technical file including IEC 60601-2-24 test data, ISO 13485 evidence, CE or FDA approval, and a clinical evaluation report. For domestic manufacturers, the route is Form MD-7 to Form MD-9 — which includes a GMP audit of your manufacturing facility in addition to a full technical file review.

Wholesale distributors need an MD-42 from the State Licensing Authority in every state where they operate. And manufacturers of Class A/B syringe pump accessories use the MD-3/MD-5 state-level pathway.

The Indian healthcare market's demand for infusion devices is growing rapidly — driven by expanding ICU infrastructure, home care adoption, and oncology treatment growth. But market access begins with a valid CDSCO license. Getting your documentation right, your device classified correctly, and your application complete the first time is the fastest path to market.

Silvereye Certifications supports both importers and manufacturers through the entire CDSCO syringe pump registration process, from first classification to final license grant.

Frequently Asked Questions